emtricitabine
Showing 1 - 25 of 761
HIV Infection Trial (dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen)
Not yet recruiting
- HIV Infection
- dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen
- (no location specified)
Aug 8, 2023
Pre-Exposure Prophylaxis of HIV Infection Trial (Lenacapavir Tablet, Lenacapavir Injection, Emtricitabine/Tenofovir Disoproxil
Not yet recruiting
- Pre-Exposure Prophylaxis of HIV Infection
- Lenacapavir Tablet
- +2 more
- (no location specified)
Oct 20, 2023
Pre-Exposure Prophylaxis of HIV Infection Trial (Lenacapavir Injection, Lenacapavir Tablet, Emtricitabine/tenofovir disoproxil
Not yet recruiting
- Pre-Exposure Prophylaxis of HIV Infection
- Lenacapavir Injection
- +2 more
- (no location specified)
Oct 20, 2023
Hiv, Hormone Therapy Trial in San Diego (Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg, Emtricitabine Tenofovir
Completed
- Hiv
- Hormone Therapy
- Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg
- Emtricitabine Tenofovir Alafenamide 200/25 mg
-
San Diego, CaliforniaUC San Diego AntiViral Research Center (AVRC)
Sep 21, 2022
HIV-1-infection Trial in Saint Louis (Biktarvy Tab)
Terminated
- HIV-1-infection
- Biktarvy Tab
-
Saint Louis, MissouriSouthampton Healthcare, Inc.
Jan 3, 2023
HIV I Infection, Cardiovascular Risk Factor, Lipid Metabolism Disorders Trial (Doravirine 100 Mg)
Recruiting
- HIV I Infection
- +2 more
- Doravirine 100 Mg
-
Los Angeles, California
- +1 more
Nov 1, 2022
Multiple Sclerosis Trial in Boston (Truvada (tenofovir/emtricitabine))
Enrolling by invitation
- Multiple Sclerosis
- Truvada (tenofovir/emtricitabine)
-
Boston, MassachusettsMassachusetts General Hospital
Jul 14, 2023
HIV I Infection Trial in Orlando (Dolutegravir / Lamivudine Pill, Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill)
Active, not recruiting
- HIV I Infection
- Dolutegravir / Lamivudine Pill
- Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill
-
Orlando, FloridaOrlando Immunology Center
Sep 20, 2022
HIV Trial in Barcelona (Biktarvy 50 mg/200 mg/25 mg film-coated tablets)
Not yet recruiting
- HIV Infections
- Biktarvy 50 mg/200 mg/25 mg film-coated tablets
-
Barcelona, SpainHospital Clinic i Provincial Barcelona
Oct 26, 2022
Exogenous and Endogenous Sex Hormones on Tenofovir and
Recruiting
- HIV/AIDS
- +2 more
- Tenofovir
- Emtricitabine
-
Minneapolis, MinnesotaUniversity of Minnesota
Mar 28, 2022
Acceptability of Health Care, Adherence, Medication Trial in Durban, Pietermaritzburg, Harare (emtricitabine/tenofovir
Recruiting
- Acceptability of Health Care
- Adherence, Medication
- emtricitabine/tenofovir alafenamide
- Emtricitabine / Tenofovir Disoproxil Oral Tablet
-
Durban, KZN, South Africa
- +2 more
Jul 12, 2022
Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)
Active, not recruiting
- Hiv
- HIV-1-infection
- Lamivudine 300 MG
- Emtricitabine / Tenofovir Disoproxil Pill
-
Buenos Aires, ArgentinaFundacion IDEAA
Jan 2, 2023
HIV-1-infection Trial in San Francisco (Bictegravir/emtricitabine/tenofovir alafenamide + Doravirine switch)
Completed
- HIV-1-infection
- Bictegravir/emtricitabine/tenofovir alafenamide + Doravirine switch
-
San Francisco, CaliforniaSFOMG Private Practice
Jan 27, 2022
HIV Trial (Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA), Cabotegravir (CAB-LA), Tenofovir
Not yet recruiting
- HIV
- Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA)
- Cabotegravir (CAB-LA), Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC)
- (no location specified)
Nov 13, 2023
HIV, Renal Transplant Rejection Trial in New York (BIKTARVY 50Mg-200Mg-25Mg Tablet)
Recruiting
- HIV Infections
- Renal Transplant Rejection
- BIKTARVY 50Mg-200Mg-25Mg Tablet
-
New York, New YorkWeill Cornell Medicine
Aug 1, 2022
HIV-1-infection Trial in Edmonton (B/F/TAF, Atripla, B/F/TAF Placebo)
Terminated
- HIV-1-infection
- B/F/TAF
- +3 more
-
Edmonton, Alberta, CanadaUniversity of Alberta
Nov 21, 2022
Aicardi Goutières Syndrome Trial in Philadelphia (Tenofovir (TDF) and Emtricitabine (FTC), Placebo)
Not yet recruiting
- Aicardi Goutières Syndrome
- Tenofovir (TDF) and Emtricitabine (FTC)
- Placebo
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Feb 8, 2022
Abacavir and Lamivudine Anabolites
Completed
- HIV-1-infection
- Blood collection
- +3 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 5, 2023
HIV-1 Infection Trial in All The Regions Of The Country (40 Centers) (Dolutegravir, Darunavir-cobicistat,
Completed
- HIV-1 Infection
- Dolutegravir
- +2 more
-
All The Regions Of The Country (40 Centers), France(unnamed)
Jan 3, 2022
HIV Trial in Houston (B/FTC/TAF, Current ART)
Terminated
- HIV Infections
- B/FTC/TAF
- Current ART
-
Houston, TexasThomas Street Health Center
Sep 1, 2022